GB782821A - Novel therapeutically active amines and salts thereof - Google Patents

Novel therapeutically active amines and salts thereof

Info

Publication number
GB782821A
GB782821A GB3720/57A GB372057A GB782821A GB 782821 A GB782821 A GB 782821A GB 3720/57 A GB3720/57 A GB 3720/57A GB 372057 A GB372057 A GB 372057A GB 782821 A GB782821 A GB 782821A
Authority
GB
United Kingdom
Prior art keywords
methyl
prepared
cyclohexen
trimethyl
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3720/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB782821A publication Critical patent/GB782821A/en
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention comprises amines of the general formula <FORM:0782821/IV (a)/1> wherein n1 is 0 or 1, and R1 represents a tertiary amino substituted alkyl radical of the formula -alkylene-R2 or a substituted benzyl radical of the formula <FORM:0782821/IV (a)/2> wherein R2 represents a tertiary-amino group and n2 is 0 or 1, and salts thereof, and the preparation thereof by reacting 1-methyl-3-[21,61,61- - trimethyl - cyclohexen - (11) - yl] - propylamine or 2-methyl-4-[21,61,61-trimethylcyclohexen - (11) - yl] - butylamine with a compound of the formula R1-X, wherein X represents the aldehyde group when R1 represents the substituted phenyl part of the above substituted benzyl radical, or X represents the aldehyde group or a halogen atom when R1 represents the above tertiary-amino substituted alkyl radical, in the presence of catalytically active hydrogen or of a basic agent (according to whether X represents the aldehyde group or a halogen respectively), and alkylating the resulting amine and, if desired, converting the product into a normal or quaternary salt. The alkyl and alkylene radicals preferably contain from 1 to 4 carbon atoms, e.g. the methyl, ethyl, propyl, dimethylene and trimethylene radicals. The alkylene radicals may be straight or branched-chain radicals. The tertiary-amino group R2 may be a dialkylamino group such as a dimethylamino radical or a saturated monocyclic 5-membered or 6-membered heterocyclic radical-particularly the pyrrolidino, piperidino or morpholino radical. The salts may be formed from inorganic acids such as hydrochloric, hydrobromic, hydriodic, sulphuric and phosphoric acids, or from organic acids such as oxalic, citric, acetic, lactic, tartaric and benzenesulphonic acids, or from quaternizing agents such as alkyl halides, dialkyl sulphates and aralkyl halides-particularly methyl bromide, ethyl iodide, butyl chloride, dimethyl sulphate and benzyl bromide. Suitable basic agents for use in the above process are alkali-metal carbonates. The alkylation step may be carried out by acylation using an organic acid anhydride or halide followed by reduction of the N-acyl compound thus formed with lithium aluminium hydride, or methylation may be carried out using a mixture of formaldehyde and formic acid. The reaction of the substituted propylamine or butylamine with the compound of the general formula R1-X, and the products so obtained are detailed in Specification 782,820. In the examples: (1) ethyl 1-methyl-3-[21,61,61-trimethyl - cyclohexen - (11) -yl] - propyl 4 - (21-diethylaminoethoxy)-benzyl amine is prepared by treating 1 - methyl - 3 - [21,61,61 - trimethylcyclohexen - (11) - yl] - propyl 4 - (21 - diethylaminoethoxy)-benzyl amine with acetyl chloride to form the hydrochloride of acetyl 1-methyl3 - [21,61,61 - trimethyl - cyclohexen - (11) - yl] - propyl 4 - (21 - diethylaminoethoxy) - benzyl amine, and liberating the free base which is then reduced with lithium aluminium hydride; the dioxalate salt of the desired product is also prepared; (2) methyl 1-methyl-3-[21,61,61-trimethyl - cyclohexen - (11) - yl] - propyl 4 - (21 - dimethylaminoethoxy-benzyl amine is prepared by treating 1-methyl-3-[21,61,61-trimethyl cyclohexen - (11) - yl] - propyl 4 - (21 - dimethylaminoethoxy) - benzyl amine with formic acid and formaldehyde, and is converted into the dioxalate salt thereof; (3) methyl 1-methyl-3-[21,61,61-trimethyl-cyclohexen - (11) - yl - propyl 3 - (21 - diethylaminoethoxy) - benzyl amine and the dioxalate thereof are prepared as in (2); (4) methyl 1-methyl-3-[21,61,61-trimethyl-cyclohexen - (11) - yl] - propyl 2 - (21 - diethylaminoethoxy)-benzylamine and the dioxalate thereof are prepared as in (2); (5) methyl 1-methyl-3-[21,61,61 - trimethyl - cyclohexen - (11) - yl] - propyl 4 - (21 - dimethylamino - isopropoxy)-benzyl amine and the dioxalate thereof are prepared as in (2); (6) methyl 1-methyl-3-[21,61,61 trimethyl - cyclohexen - (11) - yl] - propyl 4 -(31 - diethylaminopropoxy) - benzyl amine and the dioxalate thereof are prepared as in (2); (7) methyl 1 - methyl - 3 - [21,61,61 - trimethylcyclohexen - (11) - yl] - propyl 4 - (31 - piperidinopropoxy)-benzyl amine and the dioxalate thereof are prepared as in (2); (8) methyl 2-methyl-4-[21,61,61 - trimethyl - cyclohexen - (11 - yl] - butyl 4 - (21 - diethylamino - ethoxy) - benzyl amine and the dioxalate thereof are prepared as in (2); (9) methyl 2-methyl-4-[21,61,61-trimethylcyclohexen - (11) - yl] - butyl 4 - (31 - diethylaminopropoxy)-benzyl amine and the dioxalate thereof are prepared as in (2); (10) methyl 2-methyl - 4 - [21,61,61 - trimethyl - cyclohexen - (11) - yl] - butyl 4 - (31 - piperidinopropoxy) - benzyl amine and the dioxalate thereof are prepared as in (2); (11) methyl 1-methyl-3-[21,61,61-trimethyl - cyclohexen - (11) - yl] - propyl 3-piperidinopropyl amine and the dioxalate thereof are prepared as in (2), the bis-methyl bromide thereof is also prepared; and (12) methyl 2 - methyl - 4 - [21,61,61 - trimethyl - cyclohexen - (11) - yl] - butyl 3 - piperidinopropyl amine and the dioxalate thereof are prepared as in (2).
GB3720/57A 1954-09-08 1955-09-06 Novel therapeutically active amines and salts thereof Expired GB782821A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US782821XA 1954-09-08 1954-09-08

Publications (1)

Publication Number Publication Date
GB782821A true GB782821A (en) 1957-09-11

Family

ID=22143048

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3720/57A Expired GB782821A (en) 1954-09-08 1955-09-06 Novel therapeutically active amines and salts thereof

Country Status (1)

Country Link
GB (1) GB782821A (en)

Similar Documents

Publication Publication Date Title
US3381009A (en) Triazole-(4,3-a)-pyridines
JPS6051474B2 (en) 1-(Substituted amino)alkanoyl-2-(dibenzoxazepine-10-carbonyl)hydrazine derivatives and their production method
US2870145A (en) Therapeutic agents
GB850662A (en) Substituted piperazines and processes for their production
GB782821A (en) Novel therapeutically active amines and salts thereof
US2566535A (en) Quaternary ammonium salts of tertiary-aminoalkyl substituted phenylacetonitriles
US2776283A (en) 5-dialkylaminomethyl and 5-heterocyclylmethyl substituted 2-amino-6-aryl-4-pyrimidolderivatives
GB782820A (en) Novel therapeutically active amines and salts thereof and a process for the manufacture of same
US2852515A (en) Tertiary-aminoalkyl substituted tetrazoles and preparation thereof
GB618034A (en) Manufacture of basically substituted 9:10-dihydroanthracene derivatives, and their salts and amino-oxides
GB721171A (en) Derivatives of ª‰- and ª†- carbolines
GB917078A (en) Improvements in or relating to piperidine derivatives
US3139456A (en) Nu-(substituted phenoxyalkyl)-aralkylamines
ATE30718T1 (en) PREPARATION OF 1-BENZYL AZETIDIN-3-OL AND THE CORRESPONDING HALID ACID.
US2677697A (en) Basic derivatives of substituted cinnamic acids and methods of preparing same
US2744139A (en) Basic ethers of phenols
GB834281A (en) New 1-aza-(2,3:5,6)-dibenzocycloheptadiene derivatives, their acid salts and quaternary salts, and the production thereof
GB956623A (en) Phenylpiperazinone derivatives
GB789704A (en) Piperazine derivatives and their preparation
GB786384A (en) Basic alkoxyalkyl esters of phenothiazine-10-carboxylic acid and process for preparing same
GB935614A (en) Diguanidine derivatives
JPS5661373A (en) Piperazine derivative
GB845822A (en) Improvements in or relating to piperidine derivatives
GB799573A (en) Improvements in or relating to method of preparing 2-halo-10-(1-substituted-3-pyrrolidylmethyl) phenothiazines and salts thereof, and the compounds resulting therefrom
GB788915A (en) Improvements in or relating to diquaternary compounds